UK Enhances Regulation on Substandard CBD Products

The food and safety association (FSA) has specified the potential date for removing cannabidiol (CBD) products that have failed to gain regulatory approval in the UK, from the market. While speaking on the possible ban of the substandard CBD products, the FSA said in a statement on February 13 that starting from March 2021, businesses that fail to provide credible information about the health risks of their products will not be allowed to operate in the UK.

While this may seem like a drastic decision on the part of the FSA, it aims to help the good citizen of the UK stay safe from low-quality CBD products. Nevertheless, the FSA makes provisions for businesses to apply for "novel food authorization" that will help reassure the public about the safety concerns surrounding the use of their products.

Why are the Substandard CBD Products Removed from the Streets?

With the recent prominence of CBD and CBD infused products across the streets of Wales, Northern Ireland, and the UK, the need to standardize the distribution of CBD products has become progressively important. Without regulation, it would be very difficult to protect consumers from the potential side effects of substandard CBD products. The FSA believes that by stepping up the CBD regulation across its cities, consumers would be reassured and they will feel safe consuming these products. It is very common for manufacturers to hype their products and make claims that are far from the truth. This novel authorization, on the other hand, will help the public determine whether or not these products are what they claim to be.

Why are the Substandard CBD Products Removed from the Streets

FSA Warns Consumers Stay away from Substandard CBD Products

The FSA is committed to helping consumers stay safe from the potential side effects of substandard CBD products. This commitment has driven the FSA to warn consumers about the consumption and purchase of CBD infused products. This is the first-ever safety advice released by the FSA, and it aims to curb the hazards associated with CBD extracts across the UK.

While speaking about the possible ban on substandard CBD products, the FSA warned breastfeeding and expectant mothers to maintain total abstinence from CBD-infused products. Also, adult users of cannabidiol extracts should exercise caution while buying or using CBD products. To maintain a strategic distance from the health risks of CBD, the FSA encourages users to set their daily intake of CBD to 70mg (max). Unless a certified physician instigates the consumption, you should maintain strict adherence to these warnings.

Why Does FSA Enhance Regulation on Substandard CBD Products

Why Does FSA Enhance Regulation on Substandard CBD Products?

FSA enhances regulation on substandard CBD products because of its potential side effects discovered by the COT (Committee on Toxicity). It turns out that the consumption of CBD infused products and foods poses health risks to users. According to the chairman of the COT, Professor Alan Boobis, the COT has reviewed the evidence supporting CBD's potential side effects.
Whereas the research on users' vulnerability to these side effects is still ongoing, the COT has expressed its concerns for expectant mothers. According to Professor Boobis, breast-feeding women, expectant mothers, and people on medication are more at risk of incurring the potential side effects of substandard CBD products. Though the COT is yet to provide information about the risks associated with CBD foods, the FSA's pragmatic approach in stepping up CBD regulation seems like the defence.

How Do Manufacturers React to the Removal of Substandard CBD Products from the UK?

Surprisingly, manufacturers of CBD products in Wales, Northern Ireland, and the UK, have welcomed the proposed ban on substandard CBD products with open arms. The CBD industry has experienced impressive growth within the last decade. However, that growth has been greatly deterred by the risks associated with the consumption of low-quality CBD products. According to the report published by the CMC (centre for medical cannabis), the UK CBD industry is expected to hit a £1 billion benchmark by 2025. Now, with FSA stepping up CBD regulations, people can consume CBD without worrying about side effects. Consequently, this will boost growth in the UK CBD industry.

The FSA's pragmatic approach in protecting citizens while ensuring the continuous distribution of high-quality CBD is commendable. All things considered, this tactic will motivate producers to create premium quality products and maintain absolute compliance with the warnings of the FSA.

Law & regulationsVape news

Leave a comment

All comments are moderated before being published